Oxidative activation of the Ca 2 + /calmodulin-dependent protein kinase II (CaMKII) regulates vascular smooth muscle migration and apoptosis

Abstract Activation of the Ca 2 + /calmodulin-dependent protein kinase II (CaMKII) and reactive oxygen species (ROS) promote neointimal hyperplasia after vascular injury. CaMKII can be directly activated by ROS through oxidation. In this study, we determined whether abolishing the oxidative activati...

Full description

Saved in:
Bibliographic Details
Published inVascular pharmacology Vol. 60; no. 2; pp. 75 - 83
Main Authors Zhu, Linda J, Klutho, Paula J, Scott, Jason A, Xie, Litao, Luczak, Elizabeth D, Dibbern, Megan E, Prasad, Anand M, Jaffer, Omar A, Venema, Ashlee N, Nguyen, Emily K, Guan, Xiaoqun, Anderson, Mark E, Grumbach, Isabella M
Format Journal Article
LanguageEnglish
Published 2014
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Abstract Activation of the Ca 2 + /calmodulin-dependent protein kinase II (CaMKII) and reactive oxygen species (ROS) promote neointimal hyperplasia after vascular injury. CaMKII can be directly activated by ROS through oxidation. In this study, we determined whether abolishing the oxidative activation site of CaMKII alters vascular smooth muscle cell (VCMC) proliferation, migration and apoptosis in vitro and neointimal formation in vivo . VSMC isolated from a knock-in mouse with oxidation-resistant CaMKIIδ (CaMKII M2V) displayed similar proliferation but decreased migration and apoptosis. Surprisingly, ROS production and expression of the NADPH oxidase subunits p47 and p22 were decreased in M2V VSMC, whereas superoxide dismutase 2 protein expression was upregulated. In vivo , after carotid artery ligation, no differences in neointimal size or remodeling were observed. In contrast to VSMC, CaMKII expression and autonomous activity were significantly higher in M2V compared to WT carotid arteries, suggesting that an autoregulatory mechanism determines CaMKII activity in vivo . Our findings demonstrate that preventing oxidative activation of CaMKII decreases migration and apoptosis in vitro and suggest that CaMKII regulates ROS production. Our study presents novel evidence that CaMKII expression in vivo is regulated by a negative feedback loop following oxidative activation.
AbstractList Abstract Activation of the Ca 2 + /calmodulin-dependent protein kinase II (CaMKII) and reactive oxygen species (ROS) promote neointimal hyperplasia after vascular injury. CaMKII can be directly activated by ROS through oxidation. In this study, we determined whether abolishing the oxidative activation site of CaMKII alters vascular smooth muscle cell (VCMC) proliferation, migration and apoptosis in vitro and neointimal formation in vivo . VSMC isolated from a knock-in mouse with oxidation-resistant CaMKIIδ (CaMKII M2V) displayed similar proliferation but decreased migration and apoptosis. Surprisingly, ROS production and expression of the NADPH oxidase subunits p47 and p22 were decreased in M2V VSMC, whereas superoxide dismutase 2 protein expression was upregulated. In vivo , after carotid artery ligation, no differences in neointimal size or remodeling were observed. In contrast to VSMC, CaMKII expression and autonomous activity were significantly higher in M2V compared to WT carotid arteries, suggesting that an autoregulatory mechanism determines CaMKII activity in vivo . Our findings demonstrate that preventing oxidative activation of CaMKII decreases migration and apoptosis in vitro and suggest that CaMKII regulates ROS production. Our study presents novel evidence that CaMKII expression in vivo is regulated by a negative feedback loop following oxidative activation.
Author Luczak, Elizabeth D
Zhu, Linda J
Venema, Ashlee N
Xie, Litao
Scott, Jason A
Prasad, Anand M
Grumbach, Isabella M
Dibbern, Megan E
Nguyen, Emily K
Klutho, Paula J
Jaffer, Omar A
Anderson, Mark E
Guan, Xiaoqun
Author_xml – sequence: 1
  fullname: Zhu, Linda J
– sequence: 2
  fullname: Klutho, Paula J
– sequence: 3
  fullname: Scott, Jason A
– sequence: 4
  fullname: Xie, Litao
– sequence: 5
  fullname: Luczak, Elizabeth D
– sequence: 6
  fullname: Dibbern, Megan E
– sequence: 7
  fullname: Prasad, Anand M
– sequence: 8
  fullname: Jaffer, Omar A
– sequence: 9
  fullname: Venema, Ashlee N
– sequence: 10
  fullname: Nguyen, Emily K
– sequence: 11
  fullname: Guan, Xiaoqun
– sequence: 12
  fullname: Anderson, Mark E
– sequence: 13
  fullname: Grumbach, Isabella M
BookMark eNqlT0FOwzAQ9KFItMADuO0RhJLaaSnphUsEaoQQB7hbq2TbOE3syOtE8AcejSv4AXuZmdVqZ2YhZtZZEuJayVRJtVm26TQ0aSbVOpUqlVLNxFzdrx4SlW_VuVgwt3GZ55vtXHy_fZoag5kIsIoQqbPg9hAaggIhgztYVtj1rh47Y5OaBrI12QCDd4GMhaOxyARlCTcFvr6U5S14OowdBmKYkKtIPXDvXGigH7nqCHpz8L9OaGvAwQ3BseFLcbbHjunqDy_E4_PTR7FLKIrJkNdVzGBinCN9Ebdu9DbeaaU501K_n0qeOqq1jJPJ1b8f_ADJ920N
ContentType Journal Article
DOI 10.1016/j.vph.2014.01.001
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EndPage 83
ExternalDocumentID 1_s2_0_S1537189114000020
GroupedDBID ---
--K
--M
-RU
.1-
.FO
.GJ
.~1
0R~
123
1B1
1P~
1RT
1~.
1~5
29Q
4.4
457
4G.
53G
5VS
7-5
71M
8P~
AACTN
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAXKI
AAXUO
ABBQC
ABFRF
ABJNI
ABMAC
ABMZM
ABXDB
ABZDS
ACDAQ
ACGFO
ACGFS
ACRLP
ADBBV
ADEZE
ADMUD
AEBSH
AEFWE
AEKER
AENEX
AEVXI
AFCTW
AFJKZ
AFKWA
AFRHN
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AIEXJ
AIKHN
AITUG
AJOXV
AJRQY
AJUYK
AKRWK
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
AXJTR
BKOJK
BLXMC
BNPGV
CS3
DU5
EBS
EFJIC
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FIRID
FNPLU
FYGXN
G-Q
GBLVA
HVGLF
HZ~
IHE
J1W
KOM
M41
MO0
N9A
O-L
O9-
OAUVE
OA~
OGGZJ
OL0
OZT
P-8
P-9
P2P
PC.
Q38
RIG
ROL
RPZ
SDF
SDG
SDP
SES
SEW
SPCBC
SSH
SSP
SSZ
T5K
UHS
UNMZH
Z5R
~G-
ID FETCH-elsevier_clinicalkeyesjournals_1_s2_0_S15371891140000203
ISSN 1537-1891
IngestDate Tue Oct 15 22:57:18 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Reactive oxygen species
CaMKII
Migration
Proliferation
Apoptosis
Language English
LinkModel OpenURL
MergedId FETCHMERGED-elsevier_clinicalkeyesjournals_1_s2_0_S15371891140000203
ParticipantIDs elsevier_clinicalkeyesjournals_1_s2_0_S1537189114000020
PublicationCentury 2000
PublicationDate 2014
PublicationDateYYYYMMDD 2014-01-01
PublicationDate_xml – year: 2014
  text: 2014
PublicationDecade 2010
PublicationTitle Vascular pharmacology
PublicationYear 2014
SSID ssj0018869
Score 4.147956
Snippet Abstract Activation of the Ca 2 + /calmodulin-dependent protein kinase II (CaMKII) and reactive oxygen species (ROS) promote neointimal hyperplasia after...
SourceID elsevier
SourceType Publisher
StartPage 75
SubjectTerms Cardiovascular
Title Oxidative activation of the Ca 2 + /calmodulin-dependent protein kinase II (CaMKII) regulates vascular smooth muscle migration and apoptosis
URI https://www.clinicalkey.es/playcontent/1-s2.0-S1537189114000020
Volume 60
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbK9sILgg3EXecBTaAspU7TzX1BYtWmZdVg0rqp4iWyG4cF1KSa0wl44Bfwg_h5HMexm7EijT4kinJ18n2xj8-VkFdCct5LhfBDJpkfCkr9vpzgVkdySoXspamOHT7-sHN4Fh6Ne-NW63fDa2leivbkx9K4klVQxX2Iq46S_Q9k3U1xB24jvrhGhHF9K4w_fssSk7hbhydcOelPC5MD7gWI6x4uB4jDtEi0z7lvi96WXpWhIcu9r1mOI5kXRZVBlx8Po0irCi5NkXqpPOesqqYF4upN5wrb4U2zzzV7qnyvs2JWFipTTWn33F45WyTIdir8TxdzpxRYGKeG-L0uCuuz2DhwOqldS464LproiDeuS0VnJS-aKgwTNOr6212fMlOwy3bIpsBATbyg0buaGit2nO4uHQGMMuJL-2qmTU00rJKy1vqSa9m29wdD6qug3fFPdSt0I3CyWZlmr59s5kqxCuJOfOPUO2Q9wC5OO5O2fzrnIspYVUzRvZ61p1eehX81rSEGNUSb0X1yr56TwHtDsAekJfMNsnViMPu-DaNFjJ7ahi04aaC5SX45FsKChVCkgCyEAYcAPHi7jIFQMxAMAyGK4LXh3xtw7APLPjDsA8M-cOwDZB849j0k7w72R4ND375rbEN_cbCSqv6rVPyvD919RNbyIpePCXQZF6LPeJ-yJKQJ52mvm-JMV9Kks9Nn4ROyu-JDnq585TNyV0NqlHPPyVp5OZcvUFwtxcuKGX8Aeq6bzA
link.rule.ids 315,783,787,4031,27935,27936,27937
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Oxidative+activation+of+the+Ca+2+%2B+%2Fcalmodulin-dependent+protein+kinase+II+%28CaMKII%29+regulates+vascular+smooth+muscle+migration+and+apoptosis&rft.jtitle=Vascular+pharmacology&rft.au=Zhu%2C+Linda+J&rft.au=Klutho%2C+Paula+J&rft.au=Scott%2C+Jason+A&rft.au=Xie%2C+Litao&rft.date=2014&rft.issn=1537-1891&rft.volume=60&rft.issue=2&rft.spage=75&rft.epage=83&rft_id=info:doi/10.1016%2Fj.vph.2014.01.001&rft.externalDBID=ECK1-s2.0-S1537189114000020&rft.externalDocID=1_s2_0_S1537189114000020
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F15371891%2FS1537189114X00030%2Fcov150h.gif